Publication | Closed Access

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

Advanced Breast CancerBreast OncologyOncologyMedicineBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacology